<DOC>
	<DOCNO>NCT02784366</DOCNO>
	<brief_summary>The purpose study establish prospective observational cohort cancer immunotherapy patient GI side effect order identify biomarkers predict GI complication due treatment .</brief_summary>
	<brief_title>GI Complications Cancer Immunotherapy Patients</brief_title>
	<detailed_description>Primary objective - To create data bio-specimen repository enhance safety efficacy immunotherapy Secondary objective - Identify biomarkers may predict GI toxicity cancer patient undergo immunotherapy - Define clinical course intestinal inflammation identify genetic factor therapeutic response GI medication - Analyze genotype-phenotype correlation GI side effect patient undergo cancer immunotherapy</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Confirmed diagnosis cancer Currently undergo undergone immunotherapy History total colectomy History inflammatory bowel disease ( either ulcerative colitis Crohn 's disease ) History colitis chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cancer immunotherapy</keyword>
	<keyword>Ipilimumab</keyword>
</DOC>